| Business

Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan adds generic Detrol, HIV/AIDS drugs

Email Newsletters

Sign up for one of our email newsletters.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

MYL $27.29 +$0.10

at close on THURSDAY

Daily Photo Galleries

Thursday, Nov. 29, 2012, 12:40 p.m.

Mylan Inc. said on Thursday that it had introduced a generic incontinence drug to the U.S. market and was selected by the South African government as a supplier of antiretroviral drugs.

Cecil-based Mylan has started selling Tolterodine Tartrate tablets, the generic version of Detrol, made by Pfizer Inc. Tolterodine Tartrate had U.S. sales of $61.5 million for the 12 months ended Sept. 30.

The company said the South African National Department of Health selected Mylan's Indian subsidiary to supply it with 31 percent of the 30 million units of HIV/AIDS drugs it will buy in a two-year period ending Dec. 31, 2014.

Mylan's share of the contract is valued at about $127.5 million.

Add Alex Nixon to your Google+ circles.

Subscribe today! Click here for our subscription offers.




Show commenting policy

Most-Read Stories

  1. Police charge New Florence man in St. Clair officer’s killing
  2. Penn State coach fires offensive coordinator
  3. Travelers advised to arrive 2 hours early for flights from Pittsburgh International Airport
  4. New Kensington man killed in North Buffalo crash
  5. Indiana Twp. liver transplant recipient, 2, takes steps toward normal life
  6. Police officer fatally shot in New Florence; suspect in custody
  7. Aliquippa wins 16th WPIAL title, ends South Fayette’s 44-game winning streak
  8. Four downs: Steelers might still be Adams’ best bet
  9. Zatkoff’s, Malkin’s heroics not enough as Oilers down Penguins in shootout
  10. Thomas Jefferson uses defense, running game to capture WPIAL title
  11. As historic breakup nears, Alcoa works to redefine its ‘advantage’